Brief: Titan Pharmaceuticals Inc. Announces Licensing Agreement With Ocular Therapeutix Inc.
12/12/2022 15:13
Dec 12 (Reuters) - Titan Pharmaceuticals Inc TTNP.O :
* TITAN PHARMACEUTICALS INC. ANNOUNCES LICENSING AGREEMENT
WITH
OCULAR THERAPEUTIX INC.
* TITAN PHARMACEUTICALS - UNDER AGREEMENT, OCULAR TO PAY CO
UPFRONT LICENSING FEE WITH POTENTIAL FOR ADDITIONAL PAYMENTS ON
REACHING CERTAIN MILESTONES
Source text for Eikon: ID:nGNX1VXLVx
Further company coverage: TTNP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Titan Pharmaceuticals
See all newsBrief: Titan Pharmaceuticals Announces $1 Million Private Placement Of Convertible Preferred Stock
Brief: Titan Pharmaceuticals- Appoints Brynner Chiam As Acting Principal Executive Officer & Acting Principal Financial Officer Of Co
U.S. STOCKS ON THE MOVE-Newmont, Monopar Therapeutics, TKO Group
Titan Pharma falls as CEO announces resignation
Brief: Titan Pharmaceuticals Enters Into Merger Agreement With Ke Sdn. Bhd.